Article Details

Korea's GC inks deal to secure US cell and gene therapy focused CDMO - BioPharma Reporter

Retrieved on: 2022-04-19 17:38:46

Tags for this article:

Click the tags to see associated articles and topics

Korea's GC inks deal to secure US cell and gene therapy focused CDMO - BioPharma Reporter. View article details on hiswai:

Excerpt

The US CDMO manufactures autologous and allogeneic cell therapies and gene therapies, immunotherapies, including monoclonal antibodies and ...

Article found on: www.biopharma-reporter.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up